Clearstead Advisors’s iTeos Therapeutics ITOS Stock Holding History

Clearstead Advisors’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-13	Closed	-$130	–	3170
2025 Q2	$130	Buy	+13	New	+$105	﹤0.01%	2590

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Clearstead Advisors's ITOS Position: Q3 2025 in Review

Clearstead Advisors sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 13 shares — an estimated $130 sold.

Clearstead Advisors first reported a position in ITOS in Q2 2025 and held it in 1 quarter. The position peaked at $130 in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

Clearstead Advisors reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
Clearstead Advisors sold 13 iTeos Therapeutics shares in Q3 2025, an estimated $130.
Clearstead Advisors first reported a position in iTeos Therapeutics in Q2 2025 and held it in 1 quarter.
Clearstead Advisors's iTeos Therapeutics position peaked at $130 in Q2 2025.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Clearstead Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.